Frankfurt - Delayed Quote EUR
Intellia Therapeutics, Inc. (38I.F)
7.18
+0.28
+(4.09%)
As of 8:08:11 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BASTA JAMES EDMUND General Counsel | Sale | Mar 4, 2025 | 111,925 |
| BHANJI MUNA Director | Sale | Jan 29, 2025 | 19,468 |
| CLARK ELIANA Chief Technology Officer | Sale | Mar 4, 2025 | 95,369 |
| DUBE MICHAEL P Officer | Stock Award(Grant) | Feb 28, 2025 | 59,640 |
| DULAC EDWARD J III Chief Financial Officer | Stock Award(Grant) | Feb 28, 2025 | 113,524 |
| HICKS DEREK Officer | Sale | Jan 3, 2025 | 59,878 |
| LEBWOHL DAVID Officer | Stock Award(Grant) | Feb 28, 2025 | 130,866 |
| LEONARD JOHN M Chief Executive Officer | Stock Award(Grant) | Feb 28, 2025 | 1,135,530 |
| SEPP-LORENZINO LAURA Officer | Sale | Jan 3, 2025 | 77,388 |
| VERWIEL FRANK Director | Sale | Jun 17, 2024 | 17,948 |